Saturday, March 7, 2026
Home Authors Posts by Ogkologos

Ogkologos

4161 POSTS 0 COMMENTS

Trastuzumab Deruxtecan Prolongs OS in Second-Line Treatment for Patients with HER2-positive...

Ogkologos -
0

ESMO Calls for Oncology-Specific Safeguards in EU Joint Clinical Assessments of...

Ogkologos -
0

Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with...

Ogkologos -
0

Vepdegestrant Prolongs PFS in a Subgroup of Patients with ER-positive, HER2-negative...

Ogkologos -
0

Inavolisib Plus Palbociclib-Fulvestrant Prolongs OS in Patients with PIK3CA-Mutated Advanced Breast Cancer

Ogkologos -
0

FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Inavolisib

Ogkologos -
0

Improved Survival Benefit with Encorafenib plus Cetuximab plus mFOLFOX6 in First-Line...

Ogkologos -
0

ESMO Gastrointestinal Cancers Congress 2025, Barcelona, Spain, 2-5 July

Ogkologos -
0

Neoadjuvant Nivolumab Plus Chemotherapy Improves OS Among Patients with Resectable NSCLC...

Ogkologos -
0
1...222324...417Page 23 of 417

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com